日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

ERBB2扩增转移性结直肠癌一线化疗的生存结果

Matsubara, Yuki; Bando, Hideaki; Nakamura, Yoshiaki; Misumi, Toshihiro; Ng, Dionne; Tajima, Eri; Pittell, Harlan; Ohtsu, Atsushi; Yoshino, Takayuki

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

直肠癌患者接受根治性手术后分子残留病灶与复发的关系:一项前瞻性队列研究

Ando, Koji; Hamabe, Atsushi; Nakamura, Yoshiaki; Watanabe, Jun; Hirata, Keiji; Kataoka, Kozo; Miyo, Masaaki; Kato, Kentaro; Akazawa, Naoya; Kagawa, Yoshinori; Yokota, Mitsuru; Yamazaki, Kentaro; Mishima, Saori; Yukami, Hiroki; Kotani, Daisuke; Bando, Hideaki; Laliotis, George; Sharma, Shruti; Palsuledesai, Charuta C; Rabinowitz, Matthew; Jurdi, Adham; Liu, Minetta C; Aleshin, Alexey; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Yoshino, Takayuki; Oki, Eiji

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy

来自 SCRUM-MONSTAR GOZILA 子研究的循环肿瘤 DNA 分析在晚期食管鳞状细胞癌中的预后生物标志物和免疫治疗意义

Duan, Yuqing; Hashimoto, Tadayoshi; Shibuki, Taro; Taniguchi, Hiroya; Sunakawa, Yu; Komatsu, Yoshito; Takahashi, Naoki; Sato, Yuta; Yamaguchi, Kensei; Nishina, Tomohiro; Nakanoko, Tomonori; Boku, Shogen; Satoh, Taroh; Yasui, Hisateru; Esaki, Taito; Imai, Mitsuho; Fujisawa, Takao; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki

Single-Cell Analysis Identified a Recurrent Malignant-Associated Transcriptional State in Colorectal Cancer

单细胞分析鉴定出结直肠癌中一种复发性恶性相关转录状态

Iwabuchi, Sadahiro; Sawada, Kentaro; Kojima, Motohiro; Ozawa, Miho; Taniguchi, Hiroya; Bando, Hideaki; Abe, Kazumi; Kuze, Yuta; Imamura, Kiyomi; Kashima, Yukie; Hirohashi, Yoshihiko; Tajima, Atsushi; Torigoe, Toshihiko; Suzuki, Yutaka; Yoshino, Takayuki; Hashimoto, Shinichi

Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)

利用液体活检多组学和人工智能 (AI) 进行分子残留病灶 (MRD) 和多癌早期检测 (MCED) 的临床开发

Shibuki, Taro; Yamashita, Riu; Hashimoto, Tadayoshi; Fujisawa, Takao; Imai, Mitsuho; Yuda, Junichiro; Kuwata, Takeshi; Misumi, Toshihiro; Nakamura, Yoshiaki; Bando, Hideaki; Kojima, Kaname; Tokioka, Sayuri; Chiba, Ippei; Nakaya, Naoki; Hozawa, Atsushi; Koshiba, Seizo; Fuse, Nobuo; Saito, Sakae; Shimizu, Ritsuko; Park, Woong-Yang; Kinoshita, Kengo; Yoshino, Takayuki

Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors

晚期胃肠道肿瘤中基于循环肿瘤DNA分析的靶向治疗

Nakamura, Yoshiaki; Ozaki, Hiroshi; Ueno, Makoto; Komatsu, Yoshito; Yuki, Satoshi; Esaki, Taito; Taniguchi, Hiroya; Sunakawa, Yu; Yamaguchi, Kensei; Kato, Ken; Denda, Tadamichi; Nishina, Tomohiro; Takahashi, Naoki; Satoh, Taroh; Yasui, Hisateru; Satake, Hironaga; Oki, Eiji; Kato, Takeshi; Ohta, Takashi; Matsuhashi, Nobuhisa; Goto, Masahiro; Okano, Naohiro; Ohtsubo, Koushiro; Yamazaki, Kentaro; Yamashita, Riu; Iida, Naoko; Yuasa, Mihoko; Bando, Hideaki; Yoshino, Takayuki

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

在无法切除的局部晚期食管鳞状细胞癌患者中,接受根治性放化疗后使用阿特珠单抗治疗——一项多中心 2 期试验 (EPOC1802)

Bando Hideaki, Kumagai Shogo, Kotani Daisuke, Mishima Saori, Irie Takuma, Itahashi Kota, Tanaka Yosuke, Habu Takumi, Fukaya Sayuri, Kondo Masaki, Tsushima Takahiro, Hara Hiroki, Kadowaki Shigenori, Kato Ken, Chin Keisho, Yamaguchi Kensei, Kageyama Shun-Ichiro, Hojo Hidehiro, Nakamura Masaki, Tachibana Hidenobu, Wakabayashi Masashi, Fukui Makoto, Fuse Nozomu, Koyama Shohei, Mano Hiroyuki, Nishikawa Hiroyoshi, Shitara Kohei, Yoshino Takayuki, Kojima Takashi

HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer

HIBRID:基于组织学、深度学习和ctDNA的结直肠癌风险分层

Loeffler, Chiara M L; Bando, Hideaki; Sainath, Srividhya; Muti, Hannah Sophie; Jiang, Xiaofeng; van Treeck, Marko; Reitsam, Nic Gabriel; Carrero, Zunamys I; Meneghetti, Asier Rabasco; Nishikawa, Tomomi; Misumi, Toshihiro; Mishima, Saori; Kotani, Daisuke; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Oki, Eiji; Tanwei, Yuan; Durgesh, Wankhede; Foersch, Sebastian; Brenner, Hermann; Hoffmeister, Michael; Nakamura, Yoshiaki; Yoshino, Takayuki; Kather, Jakob Nikolas

A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan

一项针对未经肿瘤处理的ctDNA检测方法可检测切除的II期或III期结直肠癌中的微小残留病灶并预测复发:来自CIRCULATE-Japan的GALAXY研究的子集分析

Nakamura, Yoshiaki; Kaneva, Kristiyana; Lo, Christine; Neems, Daniel; Freaney, Jonathan E; Boulos, Hala; Hyun, Seung Won; Islam, Farahnaz; Yamada-Hanff, Jason; Driessen, Terri M; Sonnenschein, Anne; DeSantis, Dana F; Kotani, Daisuke; Watanabe, Jun; Kotaka, Masahito; Mishima, Saori; Bando, Hideaki; Yamazaki, Kentaro; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Sangli, Chithra; Tell, Robert; Blidner, Richard; Yoshino, Takayuki; Sasser, Kate; Oki, Eiji; Nimeiri, Halla

Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration

数学模型预测最佳免疫检查点抑制剂和放射疗法组合及给药时机

Sakai, Shunsuke A; Saeki, Koichi; Chi, SungGi; Hamaya, Yamato; Du, Junyan; Nakamura, Masaki; Hojo, Hidehiro; Kojima, Takashi; Nakamura, Yoshiaki; Bando, Hideaki; Kojima, Motohiro; Suzuki, Ayako; Suzuki, Yutaka; Akimoto, Tetsuo; Tsuchihara, Katsuya; Haeno, Hiroshi; Yamashita, Riu; Kageyama, Shun-Ichiro